Uncovering early markers of Parkinson's disease pathological progression using proteomics

被引：0
|
作者：
Pressey, S. N.
Murray, C. E.
Heywood, W.
Gentleman, S. M.
Mills, K.
Holton, J. L.
Gandhi, S.
Revesz, T.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1035
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [1] Uncovering early markers of Parkinson's disease pathological progression using proteomics
    Pressey, S. N.
    Murray, C. E.
    Heywood, W.
    Gentleman, S. M.
    Mills, K.
    Holton, J. L.
    Gandhi, S.
    Revesz, T.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 : 24 - 24
  • [2] Clarifying the pathological progression of Parkinson's disease
    Halliday, Glenda
    ACTA NEUROPATHOLOGICA, 2008, 115 (04) : 377 - 378
  • [3] Clarifying the pathological progression of Parkinson’s disease
    Glenda Halliday
    Acta Neuropathologica, 2008, 115 : 377 - 378
  • [4] Uncovering early markers of cardiac disease by proteomics: avoiding (heart) failure!
    Gramolini, Anthony O.
    Emili, Andrew
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (05) : 631 - 634
  • [5] Imaging Markers of Progression in Parkinson's Disease
    Strafella, Antonio P.
    Bohnen, Nico I.
    Pavese, Nicola
    Vaillancourt, David E.
    van Eimeren, Thilo
    Politis, Marios
    Tessitore, Alessandro
    Ghadery, Christine
    Lewis, Simon
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (06): : 586 - 596
  • [6] CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Ju-Hee Kang
    Brit Mollenhauer
    Christopher S. Coffey
    Jon B. Toledo
    Daniel Weintraub
    Douglas R. Galasko
    David J. Irwin
    Vivianna Van Deerlin
    Alice S. Chen-Plotkin
    Chelsea Caspell-Garcia
    Teresa Waligórska
    Peggy Taylor
    Nirali Shah
    Sarah Pan
    Pawel Zero
    Mark Frasier
    Kenneth Marek
    Karl Kieburtz
    Danna Jennings
    Caroline M. Tanner
    Tanya Simuni
    Andrew Singleton
    Arthur W. Toga
    Sohini Chowdhury
    John Q. Trojanowski
    Leslie M. Shaw
    Acta Neuropathologica, 2016, 131 : 935 - 949
  • [7] CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
    Kang, Ju-Hee
    Mollenhauer, Brit
    Coffey, Christopher S.
    Toledo, Jon B.
    Weintraub, Daniel
    Galasko, Douglas R.
    Irwin, David J.
    Van Deerlin, Vivianna
    Chen-Plotkin, Alice S.
    Caspell-Garcia, Chelsea
    Waligorska, Teresa
    Taylor, Peggy
    Shah, Nirali
    Pan, Sarah
    Zero, Pawel
    Frasier, Mark
    Marek, Kenneth
    Kieburtz, Karl
    Jennings, Danna
    Tanner, Caroline M.
    Simuni, Tanya
    Singleton, Andrew
    Toga, Arthur W.
    Chowdhury, Sohini
    Trojanowski, John Q.
    Shaw, Leslie M.
    ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 935 - 949
  • [8] Serum Inflammatory Markers and Progression of Nonmotor Symptoms in Early Parkinson's Disease
    Kim, Ryul
    Kim, Han-Joon
    Shin, Jung Hwan
    Lee, Chan Young
    Jeon, Seung Ho
    Jeon, Beomseok
    MOVEMENT DISORDERS, 2022, 37 (07) : 1535 - 1541
  • [9] Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
    Simuni, Tanya
    Siderowf, Andrew
    Lasch, Shirley
    Coffey, Chris S.
    Caspell-Garcia, Chelsea
    Jennings, Danna
    Tanner, Caroline M.
    Trojanowski, John Q.
    Shaw, Leslie M.
    Seibyl, John
    Schuff, Norbert
    Singleton, Andrew
    Kieburtz, Karl
    Toga, Arthur W.
    Mollenhauer, Brit
    Galasko, Doug
    Chahine, Lana M.
    Weintraub, Daniel
    Foroud, Tatiana
    Tosun, Duygu
    Poston, Kathleen
    Arnedo, Vanessa
    Frasier, Mark
    Sherer, Todd
    Chowdhury, Sohini
    Marek, Kenneth
    MOVEMENT DISORDERS, 2018, 33 (05) : 771 - 782
  • [10] Parkinson's Progression Markers Initiative (PPMI): Investigating Biomarker Driven Parkinson's disease (PD) Progression
    McMahon, B.
    Siderowf, A.
    Simuni, T.
    Tanner, C.
    Mollenhauer, B.
    Coffey, C.
    Galasko, D.
    Poston, K.
    Chahine, L.
    Dobkin, R.
    Foroud, T.
    Kieburtz, K.
    Weintraub, D.
    Merchant, K.
    Frasier, M.
    Sherer, T.
    Chowdury, S.
    Brown, E.
    Alcalay, R.
    Videnovic, A.
    Fabrizio, K.
    Flagg, E.
    Stanley, C.
    Marek, K.
    MOVEMENT DISORDERS, 2024, 39 : S331 - S331
12345